clinical trial · NCT07474935
Targeting Real World Usage In Stroke Treatment
Phenox GmbH·—·recruiting·n = 5,000
Saccular and Fusiform AneurysmsPseudoaneurysmVascular DissectionPerforationBifurcation AneurysmsStenosisNeurovascular AbnormaltiesWide-neck AneurysmAneurysm Treatment with a Neurovascular Flow DiverterDissection Treatment with a Neurovascular Flow DiverterPerforation Treatment with a Neurovascular Flow DiverterArteriovenous Fistula treatment with a Neurovascular Flow DiverterAneurysm Treatment with Neurovascular Stent SystemAtherosclerotic vascular stenosis Treatment with Neurovascular Stent SystemDissection Treatment with Neurovascular Stent SystemAneurysm treatment with Bifurcation Aneurysm Implant
brief summary
TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices. The overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.
started
Jan 29, 2026
primary completion
Jan 1, 2036
completion
Jan 1, 2041
last updated
Mar 16, 2026
official title
TRUST Registry - Targeting Real World Usage In Stroke Treatment A WallabyPhenox Hemorrhagic Stroke Registry
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol